BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 30820788)

  • 21. [The effect of blood-pancreatic juice barrier on 5-fluorouracil in post-pancreatoduodenectomy patients].
    Zhao Y; Liao Q; Zhu Z; Fu Q; Cai L; Zhu Y
    Zhonghua Wai Ke Za Zhi; 1999 Mar; 37(3):144-5. PubMed ID: 11829804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma.
    Sadakari Y; Ohtsuka T; Ohuchida K; Tsutsumi K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    JOP; 2010 Nov; 11(6):587-92. PubMed ID: 21068491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging Evidence for the Clinical Relevance of Pancreatic Cancer Exosomes.
    Massoumi RL; Hines OJ; Eibl G; King JC
    Pancreas; 2019 Jan; 48(1):1-8. PubMed ID: 30531240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preproenkephalin hypermethylation in the pure pancreatic juice compared with p53 mutation in the diagnosis of pancreatic carcinoma.
    Ohtsubo K; Watanabe H; Yao F; Okada G; Mouri H; Yamaguchi Y; Sawabu N
    J Gastroenterol; 2006 Aug; 41(8):791-7. PubMed ID: 16988769
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term survival of pancreatic cancer patient diagnosed by positive telomerase activity of pancreatic juice.
    Murakami Y; Uemura K; Sasaki T; Hayashidani Y; Sudo T; Sueda T
    Surgery; 2005 Nov; 138(5):962-3. PubMed ID: 16291404
    [No Abstract]   [Full Text] [Related]  

  • 26. Pancreatic cancer-derived exosomes suppress the production of GIP and GLP-1 from STC-1 cells in vitro by down-regulating the PCSK1/3.
    Zhang Y; Huang S; Li P; Chen Q; Li Y; Zhou Y; Wang L; Kang M; Zhang B; Yang B; Dong X; Wu Y
    Cancer Lett; 2018 Sep; 431():190-200. PubMed ID: 29800682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Effect of Pancreatic Juice Collection Time on the Detection of KRAS Mutations.
    Suenaga M; Dudley B; Karloski E; Borges M; Irene Canto M; Brand RE; Goggins M
    Pancreas; 2018 Jan; 47(1):35-39. PubMed ID: 29200129
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumour-derived exosomes as a signature of pancreatic cancer - liquid biopsies as indicators of tumour progression.
    Nuzhat Z; Kinhal V; Sharma S; Rice GE; Joshi V; Salomon C
    Oncotarget; 2017 Mar; 8(10):17279-17291. PubMed ID: 27999198
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biliary and pancreatic excretion of mitomycin C, with special reference to the concomitant use of urokinase].
    Suda Y; Sekine T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2225-6. PubMed ID: 3933436
    [No Abstract]   [Full Text] [Related]  

  • 30. [Pancreatic and biliary excretion of 1-(4-amino-2-methyl-5-pyrimidinyl) methyl-3-(2-chloroethyl)-3-nitrosourea hydrochloride (ACNU) in man].
    Matsuno S; Kakizaki K; Sasaki K; Sato T
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1486-90. PubMed ID: 6575728
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Penetration of ciprofloxacin into the human pancreas.
    Isenmann R; Friess H; Schlegel P; Fleischer K; Büchler MW
    Infection; 1994; 22(5):343-6. PubMed ID: 7843813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection and proteomic characterization of extracellular vesicles in human pancreatic juice.
    Osteikoetxea X; Benke M; Rodriguez M; Pálóczi K; Sódar BW; Szvicsek Z; Szabó-Taylor K; Vukman KV; Kittel Á; Wiener Z; Vékey K; Harsányi L; Szűcs Á; Turiák L; Buzás EI
    Biochem Biophys Res Commun; 2018 Apr; 499(1):37-43. PubMed ID: 29550476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transthyretin, identified by proteomics, is overabundant in pancreatic juice from pancreatic carcinoma and originates from pancreatic islets.
    Lv S; Gao J; Zhu F; Li Z; Gong Y; Xu G; Ma L
    Diagn Cytopathol; 2011 Dec; 39(12):875-81. PubMed ID: 20949480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis: Fishing for exosomes.
    Alderton GK
    Nat Rev Cancer; 2015 Aug; 15(8):453. PubMed ID: 26205334
    [No Abstract]   [Full Text] [Related]  

  • 35. MiRNAs as biomarkers of high-risk pancreatic cysts: a possible holy grail for the early detection of pancreatic cancer.
    Permuth JB; Georgeades C; Malafa M
    Future Oncol; 2015; 11(23):3105-8. PubMed ID: 26549701
    [No Abstract]   [Full Text] [Related]  

  • 36. New Insight into the Role of Exosomes in Pancreatic Cancer.
    Wang CC; Zhao YM; Wang HY; Zhao YP
    Ann Clin Lab Sci; 2019 May; 49(3):385-392. PubMed ID: 31308040
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic secretory abnormalities precede appearance of tumors of the pancreas in hamsters treated with bis-(2-oxopropyl)-N-nitrosamine.
    Rinderknecht H; Haberfelde G; Maset R; Collias K; Carmack C
    Dig Dis Sci; 1983 Jun; 28(6):526-38. PubMed ID: 6305606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioimmunoassay of lactoferrin in pancreatic juice as a test for pancreatic diseases.
    Fedail SS; Harvey RF; Salmon PR; Read AE
    Lancet; 1978 Jan; 1(8057):181-2. PubMed ID: 74606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of cytology and tumor markers of pure pancreatic juice for the diagnosis of pancreatic cancer at early stages.
    Matsumoto S; Harada H; Tanaka J; Ochi K; Seno T; Tsurumi T; Kunichika K
    Pancreas; 1994 Nov; 9(6):741-7. PubMed ID: 7846018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Abnormalities in pancreatic secretory profiles of patients with cancer of the pancreas.
    Rinderknecht H; Renner IG; Stace NH
    Dig Dis Sci; 1983 Feb; 28(2):103-10. PubMed ID: 6825532
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.